Inventor

SPROGØE KENNETT

DK30 patents

⚠️ This page may combine multiple inventors who share the name “SPROGØE KENNETT”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

SPROGØE KENNETT

ASCENDIS PHARMA BONE DISEASES AS

Controlled-release PTH compound

Controlled-release PTH compound

PTH prodrugs

PTH compounds with low peak-to-trough ratios

Dosage regimen for a controlled-release PTH compound

PTH compounds with low peak-to-trough ratios

PTH prodrugs

Controlled-release PTH compound

Incremental dose finding in controlled-release PTH compounds

Liquid pharmaceutical formulations of PTH conjugates

ASCENDIS PHARMA GROWTH DISORDERS AS

Controlled-release CNP agonists with reduced side-effects

Controlled-release CNP agonists with low initial NPR-B activity

Controlled-release CNP agonists with increased NEP stability

Controlled-release CNP agonists with increased NEP stability

CNP prodrugs with carrier attachment at the ring moiety

Controlled-release CNP agonists with low NPR-C binding

Combination therapy with controlled-release CNP agonists

Controlled-release CNP agonists with low initial NPR-B activity

Controlled-release CNP agonists with reduced side-effects

ASCENDIS PHARMA ENDOCRINOLOGY DIV A/S

PEGylated recombinant human growth hormone compounds

PEGylated recombinant human growth hormone compounds

Long-acting growth hormone dosage forms with superior efficacy to daily somatropin

Long-acting growth hormone treatment

HERSEL ULRICH

Carrier-linked treprostinil prodrugs

Carrier-linked treprostinil prodrugs

SPROGØE KENNETT

Sustained release composition of prostacyclin

Subcutaneous paliperidone composition

ASCENDIS PHARMA AS

Diagnosis, prevention and treatment of diseases of the joint

ASCENDIS PHARMA OPHTHALMOLOGY DIV A/S

VEGF neutralizing prodrugs for the treatment of ocular conditions

ASCENDIS PHARMA ONCOLOGY DIV A/S

IL-2 conjugates